8.2550
29-November-24 13:45:00
15 minutes delayed
Stocks
-0.1350
-1.61%
Today's range
8.0700 - 8.3900
ISIN
BE0974358906
Source
NASDAQ
Nyxoah receives FDA approval for full-body 1.5T and 3T MRI compatibility for the Genio® system to treat Obstructive Sleep Apnea (OSA)
09 Feb 2021 01:00:13 By Nasdaq GlobeNewswire
Nyxoah and Vanderbilt University enter exclusive licensing agreement regarding next generation neurostimulation technologies to treat Obstructive Sleep Apnea (OSA)
02 Feb 2021 00:56:05 By Nasdaq GlobeNewswire
Nyxoah announces full-body 1.5T and 3T MRI compatibility for the Genio® system to treat Obstructive Sleep Apnea (OSA)
26 Jan 2021 01:02:09 By Nasdaq GlobeNewswire
First US patient implanted in the DREAM pivotal IDE study, with the Genio® system for the treatment of Obstructive Sleep Apnea (OSA)
05 Jan 2021 01:39:42 By Nasdaq GlobeNewswire